Apellis Pharmaceuticals
APLS
A$29.08
Share price
1.07%
Change (1 day)
-51.57%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) Fails to deliver data
Key failure to deliver metrics for Apellis Pharmaceuticals:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: A$1.41 M
- Last 3 months FTD volume: A$2.66 M
- Last year FTD volume: A$2.66 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Apellis Pharmaceuticals (APLS) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Apellis Pharmaceuticals (APLS) - since 2017
Volume in USD (price x number of shares), data since 2017Apellis Pharmaceuticals (APLS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | A$6.87 M | -71.03% |
| 2024 | A$23.73 M | -68.34% |
| 2023 | A$74.94 M | 105.76% |
| 2022 | A$36.42 M | 65.93% |
| 2021 | A$21.95 M | -45.06% |
| 2020 | A$39.95 M | 228.46% |
| 2019 | A$12.16 M | -19.77% |
| 2018 | A$15.16 M | 709.9% |
| 2017 | A$1.87 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | A$2.35 M | A$10.02 M | 🇺🇸 USA |